亨斯曼材料 HUN 深 沪
已收盘 03-27 16:00:00 美东时间
12.66
+0.110
+0.88%
华盛通- 最 高12.82
- 今 开12.41
- 成交量 508.73万股
- 最 低 12.3501
- 昨 收 12.55
- 总市值 22.03亿
- 52周最高 14.2925
- 市盈率 静 --
- 换手率 2.92%
- 52周最低 7.12
- 委 比 -39.37%
- 总股本 1.74亿
- 历史最高 37.925
- 量 比 0.56
- 振 幅 3.74%
- 历史最低 -0.32
- 每 手 1
- 风险率 1.62%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Shares of chemicals-related companies are trading higher amid continued military strikes across the Middle East and lack of progress on purported U.S.-Iran talks.
Shares of chemicals-related companies are trading higher amid continued militar...
03-25 02:06
新浪财经ESG：亨斯曼材料 MSCI（明晟）ESG评级调升至A
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
03-24 10:22
Brent Hits $110, Rate-Hike Fears Hammer Stocks And Gold: What's Moving Markets Friday?
U.S. stocks fall to four-month lows as oil surges above $110, Treasury yields spike, and markets price a 50% chance of a Fed rate hike by October.
03-21 01:36
期权扫描 | 获Bernstein上调目标价，台积电期权成交激增256%！英伟达获一Call单押注涨至190美元
获Bernstein上调目标价，台积电期权成交激增256%！黄仁勋豪言万亿美元营收，英伟达获一Call单押注涨至190美元>>
03-17 19:45
Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy
A recent study published in the *Journal of Clinical Medicine* supports Vivos Therapeutics' belief that specific dental and facial morphologies are directly linked to the severity of obstructive sleep apnea (OSA). The study found that narrower palatal dental arches and higher palatal height are associated with more severe OSA. Vivos CARE devices, FDA-cleared for treating mild to severe OSA in adults and moderate-to-severe OSA in children, work by...
03-17 12:45
ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives
Telix Pharmaceuticals announced positive results from Part 1 of the ProstACT Global Phase 3 study for TLX591-Tx, a lutetium-177 radioantibody-drug conjugate. The study met its primary objectives, demonstrating acceptable safety, tolerability, and no new safety signals. Key findings include low-grade non-hematologic events, consistent dosimetry across cohorts, and no adverse drug-drug interactions. Hematologic events were transient and manageable....
03-09 23:19
Henry Schein, Vir Biotechnology, Ultra Clean Holdings And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were higher, with the Dow Jones index gaining around 200 points on ...
02-24 23:07
美股大行评级 | 潜在涨幅108.69%！Stephens & Co.维持圣玛丽石油勘测"超配"评级，上调目标价至49美元
今日重点评级关注：Stephens & Co.：维持圣玛丽石油勘测"超配"评级，目标价从48美元升至49美元；花旗：维持IDEAYA Biosciences"买入"评级，目标价从64美元升至65美元
02-20 15:57
Huntsman downgraded on valuation at J.P. Morgan after strong YTD run-up
Huntsman (HUN) -4.2% in Thursday's trading as J.P. Morgan downgraded the chemicals manufacturer to Neutral from Overweight with a $14 price target, saying the current share price now reasonably discou...
02-20 03:35
JP Morgan Downgrades Huntsman to Neutral, Raises Price Target to $14
JP Morgan analyst Jeffrey Zekauskas downgrades Huntsman (NYSE:HUN) from Overweight to Neutral and raises the price target from $11 to $14.
02-19 21:45
